CLINICAL_TRIALS
ClinicalTrials.gov record update
Whether 18F-ALF-NOTA-PRGD2 PET/CT Scan Can Predict the Efficacy and Adverse Events of Apatinib in Patients With Malignancies.
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03384511
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:36:39.991446+00:00
- Published At
- 2018-02-20T00:00:00+00:00
- Record Updated At
- 2018-02-20
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Malignancies", "Stomach Cancer", "Non-small Cell Lung Cancer", "Esophageal Cancer", "Breast Cancer", "Ovary Cancer", "Cervical Cancer"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-02-20"- protocolSection.identificationModule.nctId
"NCT03384511"- protocolSection.identificationModule.officialTitle
"Whether 18F-ALF-NOTA-PRGD2 PET/CT Scan Can Predict the Efficacy and Adverse Events of Apatinib in Patients With Malignancies."- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE4"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.